Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Tumor-Specific PROTAC development as a new therapeutic approach for osteosarcoma
Georg, G. (PI) & Pomerantz, W. C. (CoI)
ANDREW MCDONOUGH B+ FOUNDATION
1/1/26 → 12/31/27
Project: Research project
-
Slo3 inhibitors for non-hormonal male contraception
Georg, G. (PI) & Wong, H. L. (CoI)
2/15/25 → 1/31/27
Project: Research project
-
Targeting drug-resistant breast cancers with allosteric cyclin-dependent kinase 2 inhibitors
Georg, G. (PI) & Holdaway, K. (Graduate Student)
MAYO CLINIC ROCHESTER, NIH NATIONAL CANCER INSTITUTE
9/1/24 → 3/31/26
Project: Research project
-
DEL screening campaign for contraceptive and cancer targets
Georg, G. (PI)
NATIONAL INSTITUTES OF HEALTH (NIH)
8/1/24 → 7/31/26
Project: Research project
-
Catsper inhibitors for male contraception
Georg, G. (PI) & Wong, H. L. (CoI)
NIH NATL INST OF CHILD HEALTH/HUMAN DEV
2/1/24 → 1/31/27
Project: Research project
-
Discovery of Focal Adhesion Kinase (FAK) activators to promote intestinal mucosal healing
Gallardo-Macias, R., Wang, Q., Raafat Elsayed, A. A., Liu, G., Wong, H. L., Georg, G. I., Basson, M. D. & Gurvich, V. J., Mar 15 2026, In: European Journal of Medicinal Chemistry. 306, 118606.Research output: Contribution to journal › Article › peer-review
Open Access -
From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha
Shi, R., Al Noman, M. A., Mannowetz, N., Cheryala, N., Haque, E., Maitra, S., Naqvi, T., Chung, S. S. W., Bakshi, A., Hawkinson, J. E., Wong, H. L., Wolgemuth, D. J. & Georg, G. I., Jan 22 2026, In: Journal of medicinal chemistry. 69, 2, p. 1568-1605 38 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors
Williams, K. B., Larsson, A. T., Keller, B. J., Chaney, K. E., Williams, R. L., Bhunia, M. M., Draper, G. M., Jubenville, T. A., Hudson, W. A., Georg, G. I., Moertel, C. L., Ratner, N. & Largaespada, D. A., Feb 1 2026, In: Molecular Cancer Therapeutics. 25, 2, p. 230-243 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review
Shi, R., Wolgemuth, D. J. & Georg, G. I., May 2025, In: Contraception. 145, 110809.Research output: Contribution to journal › Review article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
From concept to the clinic: Retinoic acid receptor α antagonist YCT-529, an oral non-hormonal male contraceptive
Taher, N., Haque, E. & Georg, G. I., 2025, (Accepted/In press) In: Andrology.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Scopus citations